Have Been Supported With Impella
A preponderance of evidence from the FDA cVAD Study, Impella Quality Assurance
Database and physician-initiated National Cardiogenic Shock Study support
the recommendation that placing Impella 2.5 or Impella CP pre-PCI improves outcomes.
- Maini B, Scotti DJ, Gregory D. Health economics of percutaneous hemodynamic support in the treatment of high-risk cardiac patients: a systematic appraisal of the literature. Expert review of pharmacoeconomics & outcomes research. 2014;14(3):403-416.
Learn How to Improve Outcomes with the Impella Platform
Visit ProtectedPCI.com to learn about training opportunities, watch case reviews featuring
real world data and outcomes with the Impella Heart Pump.